law://eu/dec/2012/837@2026-11-20THE COUNCIL OF THE EUROPEAN UNION,Having regard to the Treaty on the Functioning of the European Union, and in particular the first subparagraph of Article 207(4), in conjunction with Article 218(6)(a)(v) thereof,Having regard to the proposal from the European Commission,Having regard to the consent of the European Parliamentnote,Whereas:
HAS ADOPTED THIS DECISION:
| Products for export to the European Union | Products for export to Australia |
|---|---|
| (1) All medical devices: (a)manufactured in Australia; and(b)subject to third party conformity assessment procedures, both product- and quality systems-related; and(c)provided for in Council Directive 90/385/EEC of 20 June 1990 on the approximation of the laws of the Member States relating to active implantable medical devices, as amended; and(d)provided for in Council Directive 93/42/EEC of 14 June 1993 concerning medical devices, as amended. | (1) All medical devices: (a)manufactured in the European Union; and(b)subject to conformity assessment procedures, both product- and quality systems-related, under the Australian Therapeutic Goods Act 1989 and Therapeutic Goods Regulations, as amended. |
| (2)For the purposes of paragraph 1:(a) medical devices provided for in the Appendix are excluded; and(b) unless otherwise provided for or by mutual arrangement by the Parties, manufacture of a medical device does not include: (i)restoration or renovation processes such as repairing, re-conditioning, overhauling or refurbishing; or(ii)operations such as pressing, labelling, ticketing, packaging and preparation for sale, conducted alone or in combination with each other; or(iii)quality control inspections alone; or(iv)sterilisation alone. | (2)For the purposes of paragraph 1:(a) medical devices provided for in the Appendix are excluded; and(b) unless otherwise provided for or by mutual arrangement by the Parties, manufacture of a medical device does not include: (i)restoration or renovation processes such as repairing, re-conditioning, overhauling or refurbishing; or(ii)operations such as pressing, labelling, ticketing, packaging and preparation for sale, conducted alone or in combination with each other; or(iii)quality control inspections alone; or(iv)sterilisation alone. |
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.
| FOR AUSTRALIA: | For medicinal products for human use:The Head of OfficeTherapeutic Goods AdministrationDepartment of Health and AgeingPO Box 100Woden ACT 2606AustraliaTel. 61-6-232-8622Fax 61-6-232-8426 |
| For medicinal products for use in animals:The Manager, Manufacturing Quality and Licensing SectionAustralian Pesticides and Veterinary Medicines AuthorityPO Box 6182Kingston ACT 2604AustraliaTel. 61-6210-4803Fax 61-6210-4741 | |
| FOR THE EUROPEAN UNION: | The Director of the European Medicines Agency7 Westferry CircusCanary WharfLondon E14 4HBUnited KingdomTel. 44-171-418 8400Fax 44-171-418 8416 |
| Legislative, regulatory and administrative requirements of the European Union with which Australian-designated conformity assessment bodies will assess compliance | Legislative, regulatory and administrative requirements of Australia with which European Union-designated conformity assessment bodies will assess compliance |
|---|---|
| Council Directive 90/385/EEC of 20 June 1990 on the approximation of the laws of the Member States relating to active implantable medical devices, as amendedCouncil Directive 93/42/EEC of 14 June 1993 concerning medical devices, as amendedand any legislation adopted on the basis of these Directives | Therapeutic Goods Act 1989, as amendedTherapeutic Goods Regulations 1990, as amendedTherapeutic Goods (Medical Devices) Regulations 2002, as amendedand any subordinate legislation referred to in the above Acts or Regulations, as amended |
| Conformity assessment bodies designated by Australia to assess products against the European Union’s legislative, regulatory and administrative requirements | Conformity assessment bodies designated by the European Union to assess products against Australia’s legislative, regulatory and administrative requirements |
|---|---|
| The lists of designated conformity assessment bodies have been mutually established by the Parties and will be maintained by them. | The lists of designated conformity assessment bodies have been mutually established by the Parties and will be maintained by them. |
| For the conformity assessment bodies designated by Australia | For the conformity assessment bodies designated by the Member States of the European Union |
|---|---|
| —Department of Health and Ageing for the Therapeutic Goods Administration | BelgiumMinistère de la Santé publique, de l’Environnement et de l’Intégration socialeMinisterie van Volksgezondheid, Leefmilieu en Sociale IntegratieAgence Fédérale des Médicaments et des Produits de Santé – Federaal Agentschap voor Geneesmiddelen en GezondheidsproductenBulgariaДържавна агенция за метрологичен и технически надзорCzech RepublicÚřad pro technickou normalizaci, metrologii a státní zkušebnictvíDenmarkIndenrigs- og SundhedsministerietLægemiddelstyrelsenGermanyZLG — Zentralstelle der Länder für Gesundheitsschutz bei Arzneimitteln und Medizinprodukten, BonnZLS — Zentralstelle der Länder für Sicherheitstechnik, MünchenEstoniaMajandus- ja KommunikatsiooniministeeriumIrelandDepartment of HealthIrish Medicines BoardGreeceΥπουργείο Υγείας και Κοινωνικής ΑλληλεγγύηςΕθνικός Οργανισμός ΦαρμάκωνSpainMinisterio de Sanidad, Política Social e IgualdadAgencia Española de Medicamentos y Productos SanitariosFranceMinistère de la SantéAgence Française de Sécurité Sanitaire des produits de SantéAgence Nationale du Médicament VétérinaireItalyMinistero della Salute – Dipartimento dell’ Innovazione – Direzione Generale Farmaci e Dispositivi MediciCyprusThe Drugs Council, Pharmaceutical Services (Ministry of Health)Veterinary Services (Ministry of Agriculture)LatviaZāļu valsts aģentūraVeselības ministrijaLithuaniaLietuvos Respublikos sveikatos apsaugos ministerijaLuxembourgMinistère de la SantéDivision de la Pharmacie et des MédicamentsHungaryOrszágos Gyógyszerészeti IntézetMaltaDirettorat tal-Affarijiet Regolatorji, Awtorità Maltija dwar l-iStandardsNetherlandsMinisterie van Volksgezondheid, Welzijn en SportInspectie voor de GezondheidszorgAustriaBundesministerium für GesundheitBundesamt für Sicherheit im GesundheitswesenPolandMinisterstwo ZdrowiaUrząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów BiobójczychPortugalINFARMED:I.P. (Autoridade Nacional do Medicamento e Produtos de Saúde, I.P.)RomaniaMinisterul Sănătății – Departament Dispozitive MedicaleSloveniaMinistrstvo za zdravjeJavna agencija Republike Slovenije za zdravila in medicinske pripomočkeSlovakiaÚrad pre normalizáciu, metrológiu a skúšobníctvo Slovenskej republikyFinlandSosiaali- ja terveysministeriöSosiaali- ja terveysalan lupa- ja valvontavirasto (Valvira)SwedenStyrelsen för ackreditering och teknisk kontroll (SWEDAC)United KingdomMedicines and Healthcare products Regulatory Agency |
| Procedures to be followed by Australia in designating conformity assessment bodies to assess products against the European Union’s requirements | Procedures to be followed by the European Union in designating conformity assessment bodies to assess products against Australia’s requirements |
|---|---|
| The Therapeutic Goods Administration of the Department of Health and Ageing will meet the requirements of the Directives listed in Section I, taking into account Decision No 768/2008/EC of the European Parliament and of the Council of 9 July 2008 on a common framework for the marketing of products, as amended, insofar as it refers to the modules for the various phases of the conformity assessment procedures and the rules for the affixing and use of the CE conformity marking, and be designated for specific categories or classes of devices and conformity assessment procedures. For products covered by Section V, designation will occur on the basis of a confidence-building programme as referred to in point 1.2 of Section V.note | Conformity assessment bodies will meet the requirements mentioned in the Directives listed in Section I, taking into account Decision No 768/2008/EC of the European Parliament and of the Council of 9 July 2008 on a common framework for the marketing of products, as amended, insofar as it refers to the modules for the various phases of the conformity assessment procedures and the rules for the affixing and use of the CE conformity marking, and be designated for specific categories or classes of devices and conformity assessment procedures. For products covered by Section V, designation will occur on the basis of a confidence-building programme as referred to in point 1.2 of Section V.note |